Table 1. Summary of nanobody generation and validation.
Primary selection and validation | Validation as intrabodies | Validation as immunolabels | ||||||
---|---|---|---|---|---|---|---|---|
Target | Phage clones selected | ELISA positives | Unique ELISA positives | COS-1 intrabody positives | Neuron intrabody positives | COS-1 IF-ICC positives | Brain IHC positives | Brain IB positives |
Homer1 | 180 | 135 | 39 | 32 | 12 | 33 | 25 | 13 |
IRSp53 | 160 | 33 | 17 | 8 | 3 | 0 | 0 | 0 |
SAPAP2 | 172 | 32 | 15 | 7 | 2 | 0 | 4 | 0 |
Gephyrin | 182 | 78 | 24 | 9 | 5 | 0 | 1 | 2 |
AMIGO-1 | 173 | 38 | 18 | 13 | 5 | 0 | 0 | 0 |